ARTICLE | Clinical News
Lucinactant regulatory update
November 8, 2010 8:00 AM UTC
FDA granted Orphan Drug designation for Discovery Lab's aerosolized KL4 surfactant to treat cystic fibrosis. The product is in Phase IIa testing for the indication. ...